CSTL · NASDAQ · Medical - Diagnostics & Research

Castle Biosciences

Provides clinician-facing molecular diagnostic tests across dermatology and gastroenterology.

$33.50
After-hours close+0.06 (+0.18%)
At close$33.44(−2.39%)
DateEstimateReportedSurprise
Nov 2026−$0.38
Jul 2026−$0.41−$0.07+82.8%
May 2026−$0.49−$0.490.0%
Feb 2026−$0.23−$0.08+65.2%
Nov 2025−$0.34−$0.02+94.1%

The latest year is open to everyone — the 30 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Sep 2019
Jul 2019
Dec 2018
Sep 2018
Jun 2018
Mar 2018
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 2, 2026−$0.38$92.1M
Jul 30, 2026−$0.41−$0.07+82.8%$86.2M$103.5M+20.1%
May 6, 2026−$0.49−$0.490.0%$79.2M$84.2M+6.3%
Feb 26, 2026−$0.23−$0.08+65.2%$79.9M$87.0M+8.9%
Nov 3, 2025−$0.34−$0.02+94.1%$80.4M$83.0M+3.3%

The latest year is open to everyone — the 30 quarters behind it read with an account.

Sign in
Aug 4, 2025
May 5, 2025
Feb 27, 2025
Nov 4, 2024
Aug 5, 2024
May 2, 2024
Feb 28, 2024
Nov 2, 2023
Aug 2, 2023
May 3, 2023
Feb 28, 2023
Nov 2, 2022
Aug 8, 2022
May 9, 2022
Feb 28, 2022
Nov 8, 2021
Aug 9, 2021
May 10, 2021
Mar 8, 2021
Nov 9, 2020
Aug 10, 2020
May 11, 2020
Mar 10, 2020
Nov 11, 2019
Sep 3, 2019
Jul 26, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018